These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36244022)

  • 1. Natural killer cells in peripheral blood at diagnosis predict response to immunosuppressive therapy in severe aplastic anemia.
    Yu W; Wang Q; Ge M; Shi X
    Clin Exp Med; 2023 Sep; 23(5):1815-1822. PubMed ID: 36244022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
    Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
    Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 7. [Increasing peripheral blood neutrophils after G-CSF treatment is a predictor of early response to immunosuppressive therapy in severe aplastic anemia].
    Wu Z; Yang W; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Zhao X; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):974-9. PubMed ID: 25417872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy.
    Guan J; Sun Y; Fu R; Wang H; Ruan E; Wang X; Qu W; Wang G; Liu H; Wu Y; Song J; Xing L; Li L; Liu H; Liu C; Shao Z
    Medicine (Baltimore); 2019 Jan; 98(3):e14149. PubMed ID: 30653151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Residual hematopoiesis is an important prognostic factor of immunosuppressive therapy in severe aplastic anemia].
    Yang W; Wu Z; Zhao X; Jing L; Zhang L; Zhou K; Peng G; Li Y; Ye L; Li Y; Li J; Fan H; Song L; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1095-9. PubMed ID: 25543704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Delayed hematologic response to immunosuppressive therapy in severe aplastic anemia].
    Yang Y; Yang WR; Wu ZJ; Zhao X; Zhang L; Jing LP; Zhou K; Li Y; Peng GX; Li Y; Li JP; Song L; Ye L; Fan HH; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1038-1043. PubMed ID: 28088966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study.
    Fang M; Song H; Zhang J; Li S; Shen D; Tang Y
    Pediatr Hematol Oncol; 2021 Oct; 38(7):633-646. PubMed ID: 33724146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia.
    Scheinberg P; Wu CO; Nunez O; Young NS
    Br J Haematol; 2009 Jan; 144(2):206-16. PubMed ID: 19036108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predicting early response to immunosuppressive therapy in severe aplastic anemia by soluble transferrin receptor assay].
    Yang WR; Xiong YY; Zhang L; Jing LP; Zhou K; Peng GX; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):709-13. PubMed ID: 23978026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
    Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
    Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
    Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
    Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
    Lawlor ER; Anderson RA; Davis JH; Fryer CJ; Pritchard SL; Rogers PC; Wu JK; Schultz KR
    J Pediatr Hematol Oncol; 1997; 19(2):115-23. PubMed ID: 9149740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased TIM-3 expression of peripheral blood natural killer cells in patients with severe aplastic anemia.
    Zhang T; Yuan X; Liu C; Li Y; Liu H; Li L; Ding K; Wang T; Wang H; Shao Z; Fu R
    Cell Immunol; 2017 Aug; 318():17-22. PubMed ID: 28637584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.